Synopsis:- Capital market stocks jumped 4–7% as RBI delayed new norms to July 1, 2026, easing near-term concerns. Regulatory clarity, intraday funding relief, and extended guarantee timelines boosted sentiment, outweighing the STT hike and driving a broad-based rally...
Synopsis:- Shares surged nearly 5% after strong FY26 business updates, with loan sanctions rising 9% to ₹51,883 crore and disbursements up 16% to ₹34,946 crore. Loan book grew 22% to ₹93,075 crore, while a ₹28 billion funding deal further strengthened the growth...
Synopsis:- Stocks remained in focus amid bulk and block deals, with a 2.7% stake worth ₹483 crore changing hands and another 4.46% stake sale of ₹42.2 crore. Select counters saw up to 3% gains, while others declined over 4%, reflecting mixed investor sentiment. Bulk...
Synopsis:- Shares surged over 7% after a ₹6,795 crore defence order, boosting sentiment. Total FY26 inflows reached ₹21,620 crore, with order book above ₹73,000 crore. Strong pipeline of ₹8,000–9,000 crore and majority ‘Buy’ ratings indicate sustained growth...
Synopsis:- Brokerage remains bullish with a ₹6,185 target, implying ~47% upside from ₹4,190. Store count reached 481 with 66 additions, exceeding expectations. Q4 saw 39 new stores. Operating profit rose to ₹1,463 crore with stable 8% margins, reflecting strong...
Synopsis:- A mix of developments highlights strong activity across sectors, including a JPY 28 billion borrowing deal, ₹57 crore solar orders, ₹500 crore fundraising, and a ₹75 crore workspace agreement. Meanwhile, infrastructure orders and R&D partnerships signal...
Synopsis:- Brokerage maintains a ‘Buy’ with ₹350 target, implying ~46% upside from ₹239. Credit growth guidance remains strong at 18–20%, with stable margins of 3.8–3.9%. Asset quality improved sharply, GNPA at 2.17%, while exposure of ₹50–60 billion to MSMEs remains...
Synopsis:- A $1 billion investment backed by global investors signals strong confidence in India’s AI-driven data centre space. With $435M, $240M, and $35M contributions and plans to scale capacity from 300 MW to 1 GW, the business is targeting 25% market share and...
Synopsis:- A healthcare stock is in focus after acquiring a leading brand to enter the ₹648 crore povidone iodine market. With 14 SKUs and strong distribution, the move boosts expansion. Operational performance improved, with operating profit rising from ₹69 crore to...
Synopsis:- Several stocks remained in focus after multiple bulk and block deals involving stakes like 6.17 lakh shares (₹58.7 crore) and 18.02 lakh shares (₹34 crore). Despite weak markets with Nifty near 22,500, these transactions highlight continued institutional...
